巨子生物控股有限公司（02367）于2025年12月29日公告翌日披露报表，披露当日回购普通股40万股，约占公司现有已发行股本的0.0374%。本次回购的每股价格介乎每股34.28港元至34.76港元，涉资总额约1381万港元。
回购完成后，尚未注销的股份数量仍计入公司已发行股本。公司已发行股本总数截至公告日维持在约10.70904亿股，库藏股数量保持为零。据公告，公司于2025年6月13日经股东大会批准的回购授权总额为1.070904亿股，至今累计已回购480万股，占回购授权时已发行股本总数的约0.4482%。
公司确认已遵守相关上市规则及适用法规。公告由公司执行董事兼联席公司秘书严鈺博签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.